10 January 2002
Brussels

Programme

9.30 - 9.40
Ms.Margaret Ewen, Co-ordinator Health Action International (HAI) Europe, and Ms. Genon Jensen, General Secretary European Public Health Alliance (EPHA)
Welcome on behalf of the organisers

9.40 - 9.45
Ms. Danielle Bardelay, Co-editor New Drug Section Prescrire, France, and representative of the International Society of Drug Bulletins (ISDB)
Introduction

Keynote speakers
9.45 - 10.10
Mr. Charles Medawar, Director Social Audit Ltd., United Kingdom
The politics of direct-to-consumer promotion of prescription medicines

10.10 - 10.35
Ms. Barbara Mintzes, Centre for Health Services and Policy Research, University of British Columbia, Canada
Who benefits from direct-to-consumer promotion of prescription medicines?

10.35 - 11.00
Coffee and tea

Keynote speakers

11.00 - 11.25
Dr. Angela Coulter, Chief Executive Picker Institute, United Kingdom, and member of G10 Medicines group
Perspective on how the EU pharmaceutical reform proposal will help provide good quality prescription medicine information

11.25- 11.50
Mr. Leon Wever, L.L.M., Director Pharmaceutical Affairs and Medical Technology, Ministry of Health, Welfare and Sport, The Netherlands
The risks of direct-to-consumer promotion from the Dutch experience in regulating drug promotion

12.00 - 12.30
Discussion

12.30 - 13.30
Lunch

13.30- 16.40
PANEL DISCUSSION
Facilitator: Dr Philip Brown, Publisher, SCRIP, United Kingdom

13.30- 15.15
5 minute presentations by panel members:

Mr. Brian Ager, Director General European Federation of Pharmaceutical Industries and Associations (EFPIA), Brussels
Pharmaceutical industry perspective on providing prescription drug information directly to the consumer in light of the EC pharmaceutical reform proposal

Mr. Arjen Broekhuizen, European AIDS Treatment Group, The Netherlands
Patients' medicine information needs

Ms. Clara MacKay, Principal Policy Advisor Consumers' Association, United Kingdom
Consumers' medicine information needs

Mr Kees de Joncheere, Regional Adviser for Pharmaceuticals and Technology, World Health Organisation, Regional Office for Europe, Denmark
Potential global public health impact of DTC promotion

Mr. Willy Palm, Director Association Internationale de la Mutualité (AIM), Brussels
The impact of DTC promotion on the cost of medicines (including experiences from the USA)

Ms. Flora Giorgio, Secretary-General Pharmaceutical Group of the European Union (PGEU), Brussels
Health professionals' role in providing prescription medicine information.

Dr. Angela Coulter

15.15 - 15.40
Coffee and tea

15.40- 16.40
PANEL DISCUSSION continued

16.40- 16.55
Prof. dr. Anita Hardon, Department of Medical Anthropology, University of Amsterdam,The Netherlands
Closing remarks

16.55- 17.00
Ms. Danielle Bardelay
Closing the day